Toxoplasma serotype is associated with development of ocular toxoplasmosis

Journal of Infectious Diseases

Volumn 208, Issue 9, 2013, Pages 1520-1528

  Shobab, Leila ^a   Pleyer, Uwe ^b   Johnsen, Joerdis ^b   Metzner, Sylvia ^b   James, Erick R ^c   Torun, N ^b   Fay, Michael P ^a   Liesenfeld, Oliver ^b   Grigg, Michael E ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diagnosis; ocular inflammatory disease; serotype; toxoplasmosis; uveitis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTOZOAL DNA;

ADOLESCENT; ADULT; AGE; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; AQUEOUS HUMOR; ARTICLE; AUTOIMMUNE UVEITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE INJURY; FEMALE; GENDER; GENE LOCUS; GENERAL PATHOLOGICAL PARAMETERS; GENOTYPE; GERMANY; HUMAN; INFANT; LESION SIZE; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONSET AGE; PARASITE LOCALIZATION; PRIORITY JOURNAL; RECURRENT INFECTION; SEROTYPE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VISUAL ACUITY;

DIAGNOSIS; OCULAR INFLAMMATORY DISEASE; SEROTYPE; TOXOPLASMOSIS; UVEITIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; CONSENSUS SEQUENCE; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PROSPECTIVE STUDIES; RECURRENCE; SEROTYPING; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; UVEITIS; YOUNG ADULT;

EID: 84885410594     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit313     Document Type: Article

References (43)

1. Dubey JP, Beattie CP. Toxoplasmosis of animals and man. CRC Press, Boca Raton, FL. pp 1-220. 1988
2. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999; 128:502-5
3. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996; 121:35-46
4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76
5. Remington JS. Toxoplasmosis in the adult. Bull N Y Acad Med 1974; 50:211-27
6. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 1992; 114:136-44
7. Holland GN. Ocular toxoplasmosis: A global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 2003; 136:973-88
8. Bosch-Driessen LH, Verbraak FD, Suttorp-Schulten MSA, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol 2002; 134:34-40
9. Saeij JP, Boyle JP, Coller S, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006; 314:1780-3
10. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2007; 445:324-7
11. Holland GN. Ocular toxoplasmosis: A global reassessment. Part II: Disease manifestations and management. Am J Ophthalmol 2004; 137:1-17
12. McLeod R, Boyer KM, Lee MA, et al. Prematurity and severity associate with T. gondii alleles (NCCCTS, 1981-2009). Clin Infect Dis 2012; 54:1595-605
13. Ajzenberg D, Banuls AL, Su C, et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol 2004; 34:1185-96
14. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. Success and virulence in Toxoplasma as the result of sexual recombination between two disctinct ancestries. Science 2001; 294:161-5
15. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 2001; 184:633-9
16. Khan A, Jordan C, Muccioli C, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular disease, Brazil. Emerg Infect Dis 2006; 12:942-9
17. Khan A, Su C, German M, Storch GA, Clifford DB, Sibley LD. Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol 2005; 43:5881-7
18. Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP. Globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci USA 2006; 103:11423-8
19. Pena HF, Gennari SM, Dubey JP, Su C. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol 2008; 38:561-9
20. Dubey JP, Velmurugan GV, Rajendran C, et al. Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol 2011; 41:1139-47
21. Howe DK, Honoré S, Derouin F, Sibley LD. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997; 35:1411-4
22. Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186:684-9
23. Nowakowska D, Colon I, Remington JS, et al. Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol 2006; 44:1382-9
24. Fekkar A, Ajzenberg D, Bodaghi B, et al. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: Predominance of type II in France. J Clin Microbiol 2011; 49:1513-7
25. Fekkar A, Bodaghi B, Touafek F, Le Hoang P, Mazier D, Paris L. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-Time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 2008; 46:1965-7
26. Kong J-T, Grigg ME, Uyetake L, Parmley S, Boothroyd JC. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 2003; 187:1484-95
27. Vaudaux JD, Muccioli C, James ER, et al. Identification of an atypical strain of toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil. J Infect Dis 2010; 202:1226-33
28. Goldmann H, Witmer R. [Antibodies in the aqueous humor]. Ophthalmologica Journal International D'ophtalmologie International Journal of Ophthalmology Zeitschrift fur Augenheilkunde 1954; 127: 323-30
29. Forrester JV. Uveitis: Pathogenesis. Lancet 1991; 338:1498-501
30. Bottos J, Miller RH, Belfort RN, Macedo AC, Belfort R, Jr., Grigg ME. Bilateral retinochoroiditis caused by an atypical strain of Toxoplasma gondii. Br J Ophthalmol 2009; 93:1546-50
31. Fay MP. Confidence intervals that match Fisher's exact or Blaker's exact tests. Biostatistics (Oxford, England) 2010; 11:373-4
32. Grigg ME, Boothroyd JC. Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene. J Clin Microbiol 2001; 39:398-400
33. Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol 2003; 41:3537-41
34. Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic Toxoplasma eye disease: Aetiology and public health implications. Epidemiol Infect 1999; 123:283-9
35. Jamieson SE, de Roubaix LA, Cortina-Borja M, et al. Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLOS ONE 2008; 3:e2285
36. Rosowski EE, Lu D, Julien L, et al. Strain-specific activation of the NFkappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 2011; 208:195-212
37. Jensen KD, Wang Y, Wojno ED, et al. Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 2011; 9:472-83
38. Reese ML, Zeiner GM, Saeij JP, Boothroyd JC, Boyle JP. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 2011; 108:9625-30
39. Steinfeldt T, Konen-Waisman S, Tong L, et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLOS Biol 2010; 8: E1000576
40. Bou G, Figueroa MS, Marti-Belda P, Navas E, Guerrero A. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol 1999; 37:3465-8
41. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973; 57:1-17
42. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982; 116:547-53
43. Silveira C, Belfort R Jr., Muccioli C, et al. The effect of long-Term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41-6